Papers: 15 Nov 2013 - 22 Nov 2013 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life. Flachenecker P, Henze T, Zettl UK Acta Neurol Scand. 2013 Nov 20. PMID: 24256407. Abstract Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. de Oliveira GLV, de Lima KWA, Colombini AM, Pinheiro DG, Panepucci RA, Palma PVB, Brum DG, Covas DT, Simões BP, de Oliveira MC, et al. Cell Transplant. 2013 Nov 20. PMID: 24256874. Abstract Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine. Iuppa CA, Diefenderfer LA Ann Pharmacother. 2013 Sep; 47(9):1223-8. PMID: 24259741. Abstract Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System. Fyffe-Maricich SL, Schott A, Karl M, Krasno J, Miller RH J Neurosci. 2013 Nov 20; 33(47):18402-8. PMID: 24259565. Abstract The incidence and prevalence of multiple sclerosis in nova scotia, Canada. Marrie R A, Fisk JD, Stadnyk KJ, Yu B N, Tremlett H, Wolfson C, Warren S, Bhan V Can J Neurol Sci. 2013 Nov; 40(6):824-31. PMID: 24257224. Abstract Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial. Rimmer JH, Wang E, Pellegrini CA, Lullo C, Gerber BS Am J Phys Med Rehabil. 2013 Dec; 92(12):1084-94. PMID: 24257266. Abstract Teriflunomide for the treatment of relapsing multiple sclerosis: a review of clinical data. Brunetti L, Wagner ML, Maroney M, Ryan M Ann Pharmacother. 2013 Sep; 47(9):1153-60. PMID: 24259730. Abstract Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis. Venci JV, Gandhi MA Ann Pharmacother. 2013 Oct 23. PMID: 24259625. Abstract Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica. Tasaki A, Shimizu F, Sano Y, Fujisawa M, Takahashi T, Haruki H, Abe M, Koga M, Kanda T J Neurol Neurosurg Psychiatry. 2013 Nov 20. PMID: 24259591. Abstract New and emerging immune-targeted drugs for the treatment of multiple sclerosis. Palmer AM Br J Clin Pharmacol. 2013 Nov 20. PMID: 24251808. Abstract Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women. Jafarzadeh A, Ebrahimi HA, Bagherzadeh S, Zarkesh F, Iranmanesh F, Najafzadeh A, Khosravimashizi A, Nemati M, Sabahi A, Hajghani H, et al. Inflammation. 2013 Nov 20. PMID: 24254331. Abstract Blood pressure normalization post-jugular venous balloon angioplasty. Sternberg Z, Grewal P, Cen S, Debarge-Igoe F, Yu J, Arata M Phlebology. 2013 Nov 19. PMID: 24255092. Abstract Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways. Xue Z, Ge Z, Zhang K, Sun R, Yang J, Han R, Peng M, Li Y, Li W, Zhang D, et al. Mol Neurobiol. 2013 Nov 21. Epub 2013 Nov 21. PMID: 24258405. Abstract P2X4 receptors control the fate and survival of activated microglia. Vázquez-Villoldo N, Domercq M, Martín A, Llop J, Gómez-Vallejo V, Matute C Glia. 2013 Nov 19. PMID: 24254916. Abstract Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan. Leoni G, Rattray M, Fulton D, Rivera A, Butt AM J Anat. 2013 Nov 20. PMID: 24252088. Abstract The molecular study of IFNβ pleiotropic roles in MS treatment. Kay M, Hojati Z, Dehghanian F Iran J Neurol. 2013; 12(4):149-156. PMID: 24250925. Abstract Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study. Moghaddasi M, Aghaei M Iran J Neurol. 2013; 12(1):9-14. PMID: 24250890. Abstract Factors affecting bone mineral density in multiple sclerosis patients. Ayatollahi A, Mohajeri-Tehrani M R, Nafissi S Iran J Neurol. 2013; 12(1):19-22. PMID: 24250892. Abstract Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis. Harirchian M H, Nasergivechi S, Maddah M, Meysamie A, Amini H, Shandiz E E, Tafakhori A Iran J Neurol. 2013; 12(1):32-4. PMID: 24250896. Abstract Clinical and demographic factors affecting disease severity in patients with multiple sclerosis. Baghizadeh S, Sahraian M A, Moghadam N B Iran J Neurol. 2013; 12(1):1-8. PMID: 24250889. Abstract Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Rezaali S, Khalilnezhad A, Naser Moghadasi A, Chaibakhsh S, Sahraian M A Iran J Neurol. 2013; 12(4):136-43. PMID: 24250923. Abstract Pituitary apoplexy presented with optic neuritis. Naser Moghadasi A, Aghakhani R, Owji M, Togha M Iran J Neurol. 2013; 12(3):117-8. PMID: 24250918. Abstract Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group. Sedighi B, Ebrahimi H A, Haghdoost A A, Abotorabi M Iran J Neurol. 2013; 12(4):125-8. PMID: 24250921. Abstract Can multiple sclerosis as a cognitive disorder influence patients' dreams? Naser Moghadasi A, Owji M Iran J Neurol. 2013; 12(2):75-6. PMID: 24250908. Abstract Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran. Talebi M, Nikanfar M, Sorkhabi R, Sharifipour E, Bahrebar M, Kiavar A, Andalib S, Khanli H M Iran J Neurol. 2013; 12(3):81-6. PMID: 24250910. Abstract Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. Zoccarato M, Saddi M V, Serra G, Pelizza M F, Rosellini I, Peddone L, Ticca A, Giometto B, Zuliani L J Neurol. 2013 Dec; 260(12):3185-7. Epub 2013 Nov 20. PMID: 24253480. Abstract Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis? Hatamian H R, Bidabadi E, Saadat S M S, Saadat N S, Kazemnezhad E, Ramezani H, Bakhshayesh B Iran J Neurol. 2013; 12(2):41-6. PMID: 24250900. Abstract Electrophysiological Evaluation of Chronic Inflammatory Demyelinating Polyneuropathy and Charcot-Marie-Tooth Type 1: Dispersion and Correlation Analysis. Kang J H, Kim H J, Lee E R J Phys Ther Sci. 2013 Oct; 25(10):1265-1268. Epub 2013 Nov 20. PMID: 24259772. Abstract Is anemia a probable cause of fatigue in patients with multiple sclerosis? Mir-Reza S, Tabatabaeiyan M, Doosti R, Owji M, Naser Moghadasi A Iran J Neurol. 2013; 12(1):35-6. PMID: 24250897. Abstract The relation between peptide hormones and sex hormone in patients with multiple sclerosis. Eftekhari E, Etemadifar M, Ebrahimi A, Baradaran S Iran J Neurol. 2013; 12(2):60-5. PMID: 24250904. Abstract Promoting Remyelination in Multiple Sclerosis-Recent Advances. Jolanda Münzel E, Williams A Drugs. 2013 Nov 16. PMID: 24242317. Abstract Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation. Tromba L, Blasi S, Vestri A, Kiltzanidi D, Tartaglia F, Redler A Phlebology. 2013 Nov 15. PMID: 24243930. Abstract Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus. Wang X-S, Wen P-F, Zhang M, Hu L-F, Ni J, Qiu L-J, Liang Y, Zhao W, Huang Q, Tao S-S, et al. Inflammation. 2013 Nov 16. PMID: 24242875. Abstract New immunological approaches in treating and diagnosing CNS diseases. Guo K, Janigro D Pharm Pat Anal. 2013 May; 2(3):361-71. PMID: 24237062. Abstract Progressive multifocal leukoencephalopathy after natalizumab discontinuation. Fine AJ, Sorbello A, Kortepeter C, Scarazzini L Ann Neurol. 2013 Nov 16. PMID: 24242357. Abstract [Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.] Mosson M, Peter L, Montel S Rev Neurol (Paris). 2013 Nov 13. PMID: 24238784. Abstract The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up. Van den Berg PJ, Visser LH PLoS One. 2013; 8(11):e78166. Epub 2013 Nov 19. PMID: 24260106. Abstract Second generation S1P pathway modulators: Research strategies and clinical developments. Bigaud M, Guerini D, Billich A, Bassilana F, Brinkmann V Biochim Biophys Acta. 2013 Nov 12. PMID: 24239768. Abstract [Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.] Bouhy D, Timmerman V Rev Neurol (Paris). 2013 Nov 13. PMID: 24238786. Abstract A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement. Leone MA, Raymkulova O, Lucenti A, Stecco A, Bolamperti L, Coppo L, Liboni W, Rivadossi G, Zaccala G, Maggio M, et al. BMJ Open. 2013; 3(11):e003508. PMID: 24240139. Abstract Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis. Soellner IA, Rabe J, Mauri V, Kaufmann J, Addicks K, Kuerten S Clin Immunol. 2013 Oct 27; 149(3PB):519-529. PMID: 24239839. Abstract Demyelinating disease in SLE: Is it multiple sclerosis or lupus? Magro Checa C, Cohen D, Bollen ELEM, Van Buchem MA, Huizinga TWJ, Steup-Beekman GM Best Pract Res Clin Rheumatol. 2013 Jun; 27(3):405-24. PMID: 24238696. Abstract Clinical Outcomes Following Surgical Management of Coexistent Cervical Stenosis and Multiple Sclerosis: A Cohort Controlled Analysis. Lubelski D, Abdullah KG, Alvin MD, Wang T, Nowacki AS, Steinmetz MP, Ransohoff RM, Benzel EC, Mroz TE Spine J. 2013 Nov 12. PMID: 24239804. Abstract A pervasive assessment of motor function: a lightweight grip strength tracking system. Lee S I, Ghasemzadeh H, Mortazavi B J, Sarrafzadeh M IEEE J Biomed Health Inform. 2013 Nov; 17(6):1023-30. PMID: 24240720. Abstract Kalopanaxsaponin A Exerts Anti-Inflammatory Effects in Lipopolysaccharide-Stimulated Microglia via Inhibition of JNK and NF-κB/AP-1 Pathways. Jeong Y-H, Hyun J-W, Kim Van Le T, Kim D-H, Kim H-S Biomol Ther (Seoul). 2013 Sep 30; 21(5):332-7. PMID: 24244819. Abstract Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy. Freedman MS Eur J Neurol. 2013 Nov 15. PMID: 24237582. Abstract Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe? Xie C, Li Z, Zhang G-X, Guan Y Mol Neurobiol. 2013 Nov 16. Epub 2013 Nov 16. PMID: 24243343. Abstract [110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)]. Fujihara K Nihon Naika Gakkai Zasshi. 2013 Sep 10; 102(9):2426-32. PMID: 24228437. Abstract What do multiple sclerosis patients and their caregivers perceive as unmet needs? Lorefice L, Mura G, Coni G, Fenu G, Sardu C, Frau J, Coghe G, Melis M, Marrosu M G, Cocco E BMC Neurol. 2013 Nov 15; 13(1):177. Epub 2013 Nov 15. PMID: 24237586. Abstract ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study. Boeru G, Milanov I, De Robertis F, Kozubski W, Lang M, Rojas-Farreras S, Tomlinson M Med Devices (Auckl). 2013; 6:175-184. Epub 2013 Nov 15. PMID: 24255602. Abstract Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity. Pisani F, Sparaneo A, Tortorella C, Ruggieri M, Trojano M, Mola M G, Nicchia G P, Frigeri A, Svelto M PLoS One. 2013; 8(11):e79185. Epub 2013 Nov 15. PMID: 24260168. Abstract Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo. Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD J Neuroinflammation. 2013 Nov 15; 10(1):138. Epub 2013 Nov 15. PMID: 24237884. Abstract Determining disease intervention strategies using spatially resolved simulations. Read M, Andrews PS, Timmis J, Williams RA, Greaves RB, Sheng H, Coles M, Kumar V PLoS One. 2013; 8(11):e80506. Epub 2013 Nov 14. PMID: 24244694. Abstract Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis? Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, Maida I, Babudieri S, Serra C, Manetti R, et al. PLoS One. 2013; 8(11):e78474. Epub 2013 Nov 13. PMID: 24236019. Abstract Modeling disease severity in multiple sclerosis using electronic health records. Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, et al. PLoS One. 2013; 8(11):e78927. Epub 2013 Nov 11. PMID: 24244385. Abstract Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia. Freilich RW, Woodbury ME, Ikezu T PLoS One. 2013; 8(11):e79416. Epub 2013 Nov 11. PMID: 24244499. Abstract Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease. Emamgholipour S, Eshaghi S M, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Sahraian M A PLoS One. 2013; 8(11). Epub 2013 Nov 07. PMID: 24244236. Abstract Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis. Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, Batocchi AP, Nemni R, Albertini R, Zaffaroni M, et al. Mult Scler Int. 2013; 2013:836486. Epub 2013 Oct 23. PMID: 24260717. Abstract Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL, Linnebank M, Valko PO Mult Scler Int. 2013; 2013:286581. Epub 2013 Oct 22. PMID: 24251039. Abstract Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome. Samadi M, Kazemi B, Golzari Oskoui S, Barzegar M J Cardiovasc Thorac Res. 2013; 5(3):81-85. Epub 2013 Oct 05. PMID: 24252981. Abstract Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia. Seada Y I, Nofel R, Sayed H M J Phys Ther Sci. 2013 Aug; 25(8):911-914. Epub 2013 Sep 20. PMID: 24259883. Abstract Myelin alters the inflammatory phenotype of macrophages by activating PPARs. Bogie JFJ, Jorissen W, Mailleux J, Nijland PG, Zelcer N, Vanmierlo T, van Horssen J, Stinissen P, Hellings N, Hendriks JJA Acta Neuropathol Commun. 2013; 1(1):43. Epub 2013 Aug 02. PMID: 24252308. Abstract Evidence of aquaporin involvement in human central pontine myelinolysis. Popescu B GF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF Acta Neuropathol Commun. 2013; 1(1):40. Epub 2013 Jul 25. PMID: 24252214. Abstract Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination. Ní Fhlathartaigh M, McMahon J, Reynolds R, Connolly D, Higgins E, Counihan T, Fitzgerald U Acta Neuropathol Commun. 2013; 1(1):37. Epub 2013 Jul 15. PMID: 24252779. Abstract Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis. Jokubaitis VG, Gresle MM, Kemper DA, Doherty W, Perreau VM, Cipriani TL, Jonas A, Shaw G, Kuhlmann T, Kilpatrick TJ, et al. Acta Neuropathol Commun. 2013; 1(1):32. Epub 2013 Jul 09. PMID: 24252604. Abstract Ocular side effects of drugs used in the treatment of multiple sclerosis. Santos-Bueso E, Serrador-García M, García-Sánchez J Arch Soc Esp Oftalmol. 2013 Dec; 88(12):493-495. Epub 2013 May 11. PMID: 24257261. Abstract Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S, Reindl M, Fujihara K, Lassmann H, Bradl M Acta Neuropathol Commun. 2013; 1(1):5. Epub 2013 May 08. PMID: 24252536. Abstract Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report. Acar A, Nuri Deniz M, Erhan E, Ugur G Anesth Pain Med. 2013 Winter; 2(3):138-40. Epub 2013 Jan 01. PMID: 24244925. Abstract New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice. Sahraian M A, Harandi A A, Kalanie H Iran J Neurol. 2012; 11(3):123-4. PMID: 24250879. Abstract Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran. Imani A, Golestani M Iran J Neurol. 2012; 11(3):87-90. PMID: 24250871. Abstract Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis. Gharagozli K, Poorsaadat L, Harandi A A, Pakdaman H, Kalanie H Iran J Neurol. 2012; 11(3):118-20. PMID: 24250877. Abstract Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis. Mazdeh M, Mobaien A R Iran J Neurol. 2012; 11(2):70-3. PMID: 24250865. Abstract Is it time to revise the classification of geographical distribution of multiple sclerosis? Sahraian M A, Pakdaman H, Harandi A A Iran J Neurol. 2012; 11(2):77-8. PMID: 24250867. Abstract A preliminary path analysis: Effect of psychopathological symptoms, mental and physical dysfunctions related to quality of life and body mass index on fatigue severity of Iranian patients with multiple sclerosis. Salehpoor G, Hosseininezhad M, Rezaei S Iran J Neurol. 2012; 11(3):96-105. PMID: 24250873. Abstract Evolutive study of relapsing-remitting multiple sclerosis with cervical proton magnetic resonance spectroscopy. A case report. Albini Riccioli L, Marliani AF, Clementi V, Bartolomei I, Agati R, Leonardi M Neuroradiol J. 2008 Oct 1; 21(4):511-7. Epub 2008 Oct 01. PMID: 24256956. Abstract Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report. Al-Turkomani AYT, Muttikkal TJE, Ben-Nakhi A Neuroradiol J. 2008 Apr 7; 21(2):166-72. Epub 2008 Apr 07. PMID: 24256821. Abstract Metabolite Changes in Normal Appearing Cervical Spinal Cord in Two Patients with Multiple Sclerosis. A Proton MR Spectroscopic Analysis. Maffei M, Marliani AF, Salvi F, Clementi V, Agati R, Leonardi M Neuroradiol J. 2008 Apr 7; 21(2):228-35. Epub 2008 Apr 07. PMID: 24256831. Abstract Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Bistolfi F Neuroradiol J. 2008 Feb 18; 21(1):10. Epub 2008 Feb 18. PMID: 24256744. Abstract Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Albini Riccioli L, D'Agostino V, Marliani AF, Leonardi M Neuroradiol J. 2008 Feb 18; 21(1):107-9. Epub 2008 Feb 18. PMID: 24256758. Abstract Employment and multiple sclerosis in new zealand. Gregory RJ, Disler P, Firth S J Occup Rehabil. 1993 Jun; 3(2):113-7. PMID: 24243231. Abstract Multiple sclerosis : A multielement survey. Ward NI, Bryce-Smith D, Minski M, Matthews WB Biol Trace Elem Res. 1985 Apr; 7(3):153-9. PMID: 24259117. Abstract
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life. Flachenecker P, Henze T, Zettl UK Acta Neurol Scand. 2013 Nov 20. PMID: 24256407. Abstract
Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. de Oliveira GLV, de Lima KWA, Colombini AM, Pinheiro DG, Panepucci RA, Palma PVB, Brum DG, Covas DT, Simões BP, de Oliveira MC, et al. Cell Transplant. 2013 Nov 20. PMID: 24256874. Abstract
Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine. Iuppa CA, Diefenderfer LA Ann Pharmacother. 2013 Sep; 47(9):1223-8. PMID: 24259741. Abstract
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System. Fyffe-Maricich SL, Schott A, Karl M, Krasno J, Miller RH J Neurosci. 2013 Nov 20; 33(47):18402-8. PMID: 24259565. Abstract
The incidence and prevalence of multiple sclerosis in nova scotia, Canada. Marrie R A, Fisk JD, Stadnyk KJ, Yu B N, Tremlett H, Wolfson C, Warren S, Bhan V Can J Neurol Sci. 2013 Nov; 40(6):824-31. PMID: 24257224. Abstract
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial. Rimmer JH, Wang E, Pellegrini CA, Lullo C, Gerber BS Am J Phys Med Rehabil. 2013 Dec; 92(12):1084-94. PMID: 24257266. Abstract
Teriflunomide for the treatment of relapsing multiple sclerosis: a review of clinical data. Brunetti L, Wagner ML, Maroney M, Ryan M Ann Pharmacother. 2013 Sep; 47(9):1153-60. PMID: 24259730. Abstract
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis. Venci JV, Gandhi MA Ann Pharmacother. 2013 Oct 23. PMID: 24259625. Abstract
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica. Tasaki A, Shimizu F, Sano Y, Fujisawa M, Takahashi T, Haruki H, Abe M, Koga M, Kanda T J Neurol Neurosurg Psychiatry. 2013 Nov 20. PMID: 24259591. Abstract
New and emerging immune-targeted drugs for the treatment of multiple sclerosis. Palmer AM Br J Clin Pharmacol. 2013 Nov 20. PMID: 24251808. Abstract
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women. Jafarzadeh A, Ebrahimi HA, Bagherzadeh S, Zarkesh F, Iranmanesh F, Najafzadeh A, Khosravimashizi A, Nemati M, Sabahi A, Hajghani H, et al. Inflammation. 2013 Nov 20. PMID: 24254331. Abstract
Blood pressure normalization post-jugular venous balloon angioplasty. Sternberg Z, Grewal P, Cen S, Debarge-Igoe F, Yu J, Arata M Phlebology. 2013 Nov 19. PMID: 24255092. Abstract
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways. Xue Z, Ge Z, Zhang K, Sun R, Yang J, Han R, Peng M, Li Y, Li W, Zhang D, et al. Mol Neurobiol. 2013 Nov 21. Epub 2013 Nov 21. PMID: 24258405. Abstract
P2X4 receptors control the fate and survival of activated microglia. Vázquez-Villoldo N, Domercq M, Martín A, Llop J, Gómez-Vallejo V, Matute C Glia. 2013 Nov 19. PMID: 24254916. Abstract
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan. Leoni G, Rattray M, Fulton D, Rivera A, Butt AM J Anat. 2013 Nov 20. PMID: 24252088. Abstract
The molecular study of IFNβ pleiotropic roles in MS treatment. Kay M, Hojati Z, Dehghanian F Iran J Neurol. 2013; 12(4):149-156. PMID: 24250925. Abstract
Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study. Moghaddasi M, Aghaei M Iran J Neurol. 2013; 12(1):9-14. PMID: 24250890. Abstract
Factors affecting bone mineral density in multiple sclerosis patients. Ayatollahi A, Mohajeri-Tehrani M R, Nafissi S Iran J Neurol. 2013; 12(1):19-22. PMID: 24250892. Abstract
Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis. Harirchian M H, Nasergivechi S, Maddah M, Meysamie A, Amini H, Shandiz E E, Tafakhori A Iran J Neurol. 2013; 12(1):32-4. PMID: 24250896. Abstract
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis. Baghizadeh S, Sahraian M A, Moghadam N B Iran J Neurol. 2013; 12(1):1-8. PMID: 24250889. Abstract
Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Rezaali S, Khalilnezhad A, Naser Moghadasi A, Chaibakhsh S, Sahraian M A Iran J Neurol. 2013; 12(4):136-43. PMID: 24250923. Abstract
Pituitary apoplexy presented with optic neuritis. Naser Moghadasi A, Aghakhani R, Owji M, Togha M Iran J Neurol. 2013; 12(3):117-8. PMID: 24250918. Abstract
Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group. Sedighi B, Ebrahimi H A, Haghdoost A A, Abotorabi M Iran J Neurol. 2013; 12(4):125-8. PMID: 24250921. Abstract
Can multiple sclerosis as a cognitive disorder influence patients' dreams? Naser Moghadasi A, Owji M Iran J Neurol. 2013; 12(2):75-6. PMID: 24250908. Abstract
Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran. Talebi M, Nikanfar M, Sorkhabi R, Sharifipour E, Bahrebar M, Kiavar A, Andalib S, Khanli H M Iran J Neurol. 2013; 12(3):81-6. PMID: 24250910. Abstract
Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. Zoccarato M, Saddi M V, Serra G, Pelizza M F, Rosellini I, Peddone L, Ticca A, Giometto B, Zuliani L J Neurol. 2013 Dec; 260(12):3185-7. Epub 2013 Nov 20. PMID: 24253480. Abstract
Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis? Hatamian H R, Bidabadi E, Saadat S M S, Saadat N S, Kazemnezhad E, Ramezani H, Bakhshayesh B Iran J Neurol. 2013; 12(2):41-6. PMID: 24250900. Abstract
Electrophysiological Evaluation of Chronic Inflammatory Demyelinating Polyneuropathy and Charcot-Marie-Tooth Type 1: Dispersion and Correlation Analysis. Kang J H, Kim H J, Lee E R J Phys Ther Sci. 2013 Oct; 25(10):1265-1268. Epub 2013 Nov 20. PMID: 24259772. Abstract
Is anemia a probable cause of fatigue in patients with multiple sclerosis? Mir-Reza S, Tabatabaeiyan M, Doosti R, Owji M, Naser Moghadasi A Iran J Neurol. 2013; 12(1):35-6. PMID: 24250897. Abstract
The relation between peptide hormones and sex hormone in patients with multiple sclerosis. Eftekhari E, Etemadifar M, Ebrahimi A, Baradaran S Iran J Neurol. 2013; 12(2):60-5. PMID: 24250904. Abstract
Promoting Remyelination in Multiple Sclerosis-Recent Advances. Jolanda Münzel E, Williams A Drugs. 2013 Nov 16. PMID: 24242317. Abstract
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation. Tromba L, Blasi S, Vestri A, Kiltzanidi D, Tartaglia F, Redler A Phlebology. 2013 Nov 15. PMID: 24243930. Abstract
Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus. Wang X-S, Wen P-F, Zhang M, Hu L-F, Ni J, Qiu L-J, Liang Y, Zhao W, Huang Q, Tao S-S, et al. Inflammation. 2013 Nov 16. PMID: 24242875. Abstract
New immunological approaches in treating and diagnosing CNS diseases. Guo K, Janigro D Pharm Pat Anal. 2013 May; 2(3):361-71. PMID: 24237062. Abstract
Progressive multifocal leukoencephalopathy after natalizumab discontinuation. Fine AJ, Sorbello A, Kortepeter C, Scarazzini L Ann Neurol. 2013 Nov 16. PMID: 24242357. Abstract
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.] Mosson M, Peter L, Montel S Rev Neurol (Paris). 2013 Nov 13. PMID: 24238784. Abstract
The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up. Van den Berg PJ, Visser LH PLoS One. 2013; 8(11):e78166. Epub 2013 Nov 19. PMID: 24260106. Abstract
Second generation S1P pathway modulators: Research strategies and clinical developments. Bigaud M, Guerini D, Billich A, Bassilana F, Brinkmann V Biochim Biophys Acta. 2013 Nov 12. PMID: 24239768. Abstract
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.] Bouhy D, Timmerman V Rev Neurol (Paris). 2013 Nov 13. PMID: 24238786. Abstract
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement. Leone MA, Raymkulova O, Lucenti A, Stecco A, Bolamperti L, Coppo L, Liboni W, Rivadossi G, Zaccala G, Maggio M, et al. BMJ Open. 2013; 3(11):e003508. PMID: 24240139. Abstract
Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis. Soellner IA, Rabe J, Mauri V, Kaufmann J, Addicks K, Kuerten S Clin Immunol. 2013 Oct 27; 149(3PB):519-529. PMID: 24239839. Abstract
Demyelinating disease in SLE: Is it multiple sclerosis or lupus? Magro Checa C, Cohen D, Bollen ELEM, Van Buchem MA, Huizinga TWJ, Steup-Beekman GM Best Pract Res Clin Rheumatol. 2013 Jun; 27(3):405-24. PMID: 24238696. Abstract
Clinical Outcomes Following Surgical Management of Coexistent Cervical Stenosis and Multiple Sclerosis: A Cohort Controlled Analysis. Lubelski D, Abdullah KG, Alvin MD, Wang T, Nowacki AS, Steinmetz MP, Ransohoff RM, Benzel EC, Mroz TE Spine J. 2013 Nov 12. PMID: 24239804. Abstract
A pervasive assessment of motor function: a lightweight grip strength tracking system. Lee S I, Ghasemzadeh H, Mortazavi B J, Sarrafzadeh M IEEE J Biomed Health Inform. 2013 Nov; 17(6):1023-30. PMID: 24240720. Abstract
Kalopanaxsaponin A Exerts Anti-Inflammatory Effects in Lipopolysaccharide-Stimulated Microglia via Inhibition of JNK and NF-κB/AP-1 Pathways. Jeong Y-H, Hyun J-W, Kim Van Le T, Kim D-H, Kim H-S Biomol Ther (Seoul). 2013 Sep 30; 21(5):332-7. PMID: 24244819. Abstract
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy. Freedman MS Eur J Neurol. 2013 Nov 15. PMID: 24237582. Abstract
Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe? Xie C, Li Z, Zhang G-X, Guan Y Mol Neurobiol. 2013 Nov 16. Epub 2013 Nov 16. PMID: 24243343. Abstract
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)]. Fujihara K Nihon Naika Gakkai Zasshi. 2013 Sep 10; 102(9):2426-32. PMID: 24228437. Abstract
What do multiple sclerosis patients and their caregivers perceive as unmet needs? Lorefice L, Mura G, Coni G, Fenu G, Sardu C, Frau J, Coghe G, Melis M, Marrosu M G, Cocco E BMC Neurol. 2013 Nov 15; 13(1):177. Epub 2013 Nov 15. PMID: 24237586. Abstract
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study. Boeru G, Milanov I, De Robertis F, Kozubski W, Lang M, Rojas-Farreras S, Tomlinson M Med Devices (Auckl). 2013; 6:175-184. Epub 2013 Nov 15. PMID: 24255602. Abstract
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity. Pisani F, Sparaneo A, Tortorella C, Ruggieri M, Trojano M, Mola M G, Nicchia G P, Frigeri A, Svelto M PLoS One. 2013; 8(11):e79185. Epub 2013 Nov 15. PMID: 24260168. Abstract
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo. Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD J Neuroinflammation. 2013 Nov 15; 10(1):138. Epub 2013 Nov 15. PMID: 24237884. Abstract
Determining disease intervention strategies using spatially resolved simulations. Read M, Andrews PS, Timmis J, Williams RA, Greaves RB, Sheng H, Coles M, Kumar V PLoS One. 2013; 8(11):e80506. Epub 2013 Nov 14. PMID: 24244694. Abstract
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis? Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, Maida I, Babudieri S, Serra C, Manetti R, et al. PLoS One. 2013; 8(11):e78474. Epub 2013 Nov 13. PMID: 24236019. Abstract
Modeling disease severity in multiple sclerosis using electronic health records. Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, et al. PLoS One. 2013; 8(11):e78927. Epub 2013 Nov 11. PMID: 24244385. Abstract
Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia. Freilich RW, Woodbury ME, Ikezu T PLoS One. 2013; 8(11):e79416. Epub 2013 Nov 11. PMID: 24244499. Abstract
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease. Emamgholipour S, Eshaghi S M, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Sahraian M A PLoS One. 2013; 8(11). Epub 2013 Nov 07. PMID: 24244236. Abstract
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis. Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, Batocchi AP, Nemni R, Albertini R, Zaffaroni M, et al. Mult Scler Int. 2013; 2013:836486. Epub 2013 Oct 23. PMID: 24260717. Abstract
Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pöhlau D, Bassetti CL, Linnebank M, Valko PO Mult Scler Int. 2013; 2013:286581. Epub 2013 Oct 22. PMID: 24251039. Abstract
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome. Samadi M, Kazemi B, Golzari Oskoui S, Barzegar M J Cardiovasc Thorac Res. 2013; 5(3):81-85. Epub 2013 Oct 05. PMID: 24252981. Abstract
Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia. Seada Y I, Nofel R, Sayed H M J Phys Ther Sci. 2013 Aug; 25(8):911-914. Epub 2013 Sep 20. PMID: 24259883. Abstract
Myelin alters the inflammatory phenotype of macrophages by activating PPARs. Bogie JFJ, Jorissen W, Mailleux J, Nijland PG, Zelcer N, Vanmierlo T, van Horssen J, Stinissen P, Hellings N, Hendriks JJA Acta Neuropathol Commun. 2013; 1(1):43. Epub 2013 Aug 02. PMID: 24252308. Abstract
Evidence of aquaporin involvement in human central pontine myelinolysis. Popescu B GF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF Acta Neuropathol Commun. 2013; 1(1):40. Epub 2013 Jul 25. PMID: 24252214. Abstract
Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination. Ní Fhlathartaigh M, McMahon J, Reynolds R, Connolly D, Higgins E, Counihan T, Fitzgerald U Acta Neuropathol Commun. 2013; 1(1):37. Epub 2013 Jul 15. PMID: 24252779. Abstract
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis. Jokubaitis VG, Gresle MM, Kemper DA, Doherty W, Perreau VM, Cipriani TL, Jonas A, Shaw G, Kuhlmann T, Kilpatrick TJ, et al. Acta Neuropathol Commun. 2013; 1(1):32. Epub 2013 Jul 09. PMID: 24252604. Abstract
Ocular side effects of drugs used in the treatment of multiple sclerosis. Santos-Bueso E, Serrador-García M, García-Sánchez J Arch Soc Esp Oftalmol. 2013 Dec; 88(12):493-495. Epub 2013 May 11. PMID: 24257261. Abstract
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S, Reindl M, Fujihara K, Lassmann H, Bradl M Acta Neuropathol Commun. 2013; 1(1):5. Epub 2013 May 08. PMID: 24252536. Abstract
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report. Acar A, Nuri Deniz M, Erhan E, Ugur G Anesth Pain Med. 2013 Winter; 2(3):138-40. Epub 2013 Jan 01. PMID: 24244925. Abstract
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice. Sahraian M A, Harandi A A, Kalanie H Iran J Neurol. 2012; 11(3):123-4. PMID: 24250879. Abstract
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran. Imani A, Golestani M Iran J Neurol. 2012; 11(3):87-90. PMID: 24250871. Abstract
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosis. Gharagozli K, Poorsaadat L, Harandi A A, Pakdaman H, Kalanie H Iran J Neurol. 2012; 11(3):118-20. PMID: 24250877. Abstract
Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis. Mazdeh M, Mobaien A R Iran J Neurol. 2012; 11(2):70-3. PMID: 24250865. Abstract
Is it time to revise the classification of geographical distribution of multiple sclerosis? Sahraian M A, Pakdaman H, Harandi A A Iran J Neurol. 2012; 11(2):77-8. PMID: 24250867. Abstract
A preliminary path analysis: Effect of psychopathological symptoms, mental and physical dysfunctions related to quality of life and body mass index on fatigue severity of Iranian patients with multiple sclerosis. Salehpoor G, Hosseininezhad M, Rezaei S Iran J Neurol. 2012; 11(3):96-105. PMID: 24250873. Abstract
Evolutive study of relapsing-remitting multiple sclerosis with cervical proton magnetic resonance spectroscopy. A case report. Albini Riccioli L, Marliani AF, Clementi V, Bartolomei I, Agati R, Leonardi M Neuroradiol J. 2008 Oct 1; 21(4):511-7. Epub 2008 Oct 01. PMID: 24256956. Abstract
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report. Al-Turkomani AYT, Muttikkal TJE, Ben-Nakhi A Neuroradiol J. 2008 Apr 7; 21(2):166-72. Epub 2008 Apr 07. PMID: 24256821. Abstract
Metabolite Changes in Normal Appearing Cervical Spinal Cord in Two Patients with Multiple Sclerosis. A Proton MR Spectroscopic Analysis. Maffei M, Marliani AF, Salvi F, Clementi V, Agati R, Leonardi M Neuroradiol J. 2008 Apr 7; 21(2):228-35. Epub 2008 Apr 07. PMID: 24256831. Abstract
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Bistolfi F Neuroradiol J. 2008 Feb 18; 21(1):10. Epub 2008 Feb 18. PMID: 24256744. Abstract
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Albini Riccioli L, D'Agostino V, Marliani AF, Leonardi M Neuroradiol J. 2008 Feb 18; 21(1):107-9. Epub 2008 Feb 18. PMID: 24256758. Abstract
Employment and multiple sclerosis in new zealand. Gregory RJ, Disler P, Firth S J Occup Rehabil. 1993 Jun; 3(2):113-7. PMID: 24243231. Abstract
Multiple sclerosis : A multielement survey. Ward NI, Bryce-Smith D, Minski M, Matthews WB Biol Trace Elem Res. 1985 Apr; 7(3):153-9. PMID: 24259117. Abstract